Cargando…
Metformin and Its Sulfenamide Prodrugs Inhibit Human Cholinesterase Activity
The results of epidemiological and pathophysiological studies suggest that type 2 diabetes mellitus (T2DM) may predispose to Alzheimer's disease (AD). The two conditions present similar glucose levels, insulin resistance, and biochemical etiologies such as inflammation and oxidative stress. The...
Autores principales: | Markowicz-Piasecka, Magdalena, Sikora, Joanna, Mateusiak, Łukasz, Mikiciuk-Olasik, Elżbieta, Huttunen, Kristiina M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523189/ https://www.ncbi.nlm.nih.gov/pubmed/28770024 http://dx.doi.org/10.1155/2017/7303096 |
Ejemplares similares
-
Sulfenamide and Sulfonamide Derivatives of Metformin – A New Option to Improve Endothelial Function and Plasma Haemostasis
por: Markowicz-Piasecka, Magdalena, et al.
Publicado: (2019) -
Metformin and its sulphonamide derivative simultaneously potentiateanti-cholinesterase activity of donepezil and inhibit beta-amyloid aggregation
por: Markowicz-Piasecka, Magdalena, et al.
Publicado: (2018) -
Metformin – a Future Therapy for Neurodegenerative Diseases: Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla
por: Markowicz-Piasecka, Magdalena, et al.
Publicado: (2017) -
Extract of Aronia melanocarpa-modified hemostasis: in vitro studies
por: Sikora, Joanna, et al.
Publicado: (2014) -
Synthesis and Biocompatibility Studies of New Iminodiacetic Acid Derivatives
por: Markowicz-Piasecka, Magdalena, et al.
Publicado: (2017)